PathGroup Expands Operations with Proscia Concentiq Dx

By Author Proscia | March 3, 2023

In a wide-ranging Q&A, Proscia Co-founder and Chief Product Officer Nathan Buchbinder outlines why digital pathology adoption will be aided by a new set of CPT codes, and how it is already proving beneficial to diagnostics laboratories just a few years after its first FDA approval.

Our website uses cookies. By using this site, you agree to its use of cookies.